Analysis of the Study of the Expression of Apoptosis Markers (CD95) and Intercellular Adhesion Markers (CD54) in Healthy Individuals and Patients Who Underwent COVID-19 When Using the Drug Mercureid
Journal Title: Journal of Clinical Immunology & Microbiology - Year 2021, Vol 2, Issue 2
Abstract
SARS-CoV-2, the pathogen, which is responsible for coronavirus disease 2019 (COVID-19), has caused unprecedented morbidity and mortality worldwide. Scientific and clinical evidence testifies about long-term COVID-19 effects that can affect many organ systems. Cellular damage, overproduction of proinflammatory cytokines and procoagulant abnormalities caused by SARS-CoV-2 infection may lead to these consequences. After suffering from COVID-19, a negative PCR test is only the beginning of a difficult path to full recovery. 61 % of patients will continue to have the signs of post-covid syndrome with the risk of developing serious COVID-19 health complications for a long time. Post-COVID syndrome is an underestimated large-scale problem that can lead to the collapse of the healthcare system in the nearest future. The treatment and prevention of post-covid syndrome require integrated rather than organ or disease specific approaches and there is an urgent need to conduct a special research to establish the risk factors. For this purpose, we studied the expression of markers of apoptosis (CD95) and intercellular adhesion (CD54) in healthy individuals and patients who underwent COVID-19, as well as the efficacy of the drug Mercureid for the treatment of post-covid syndrome. The expression level of the apoptosis marker CD95 in patients who underwent COVID-19 is 1.7-2.5 times higher than the norm and the intercellular adhesion marker CD54 is 2.9-4.4 times higher. This fact indicates a persistent high level of dysfunctional immune response in the short term after recovery. The severity of the expression of the intercellular adhesion molecule (ICAM-1, CD54) shows the involvement of the endothelium of the vascular wall in the inflammatory process as one of the mechanisms of the pathogenesis of post-covid syndrome. The use of Mercureid made it possible to reduce the overexpression of CD95 in 73.4 % of patients that led to the restoration of the number of CD4+/CD8+ T-cells, which are crucial in the restoration of functionally active antiviral and antitumor immunity of patients. Also, the use of Mercureid led to a normalization of ICAM-1 (CD54) levels in 75.8 % of patients. The pharmacological properties of the new targeted immunotherapy drug Mercureid provide new therapeutic opportunities for the physician to influence a number of therapeutic targets, such as CD95, ICAM-1 (CD54), to reduce the risk of post-COVID complications.
Authors and Affiliations
Sergey N Gusev*, Velichko LN, Bogdanova AV, Khramenko NI, Konovalova NV
Keywords
Related Articles
- EP ID EP699102
- DOI http://dx.doi.org/10.46889/JCIM.2021.2205
- Views 80
- Downloads 0
Outcome of Different Therapeutic Interventions in Mild COVID-19 Infection
Background: Coronavirus disease 2019 (COVID-19) case and the death toll has reached milestones of over 12,28,22,505 and 27,09,041 respectively worldwide as of 22nd March 2021. Treatment regimens are cropping up daily a...
Is Diabetes Epidemic? – Symbiosis as Collective Consciousness
According to recent CDC data, in the US 10.5% of the population has diabetes, but another 21.4% are not diagnosed. This totals to 1/3 of the US population having diabetes in 2019 and the number steadily increases every...
Attachment of Salmonella Typhimurium to Fish Surfaces from a Suspension in Seawater and the Effect of Subsequent Washing
Background: Salmonella contamination of seafood is an important consumer health concern. Anthropogenic contamination of coastal-marine water is an important source of seafood contamination with Salmonella. In this study...
A Rapidly Progressive Case of Skin and Soft Tissues Necrosis in a COVID-19 Positive Patient
Sars-Cov2 infection can result in numerous and varied skin manifestations including vasculopathy, bullous lesions and rarely necrotic lesions. At present, the aetiopathogenetic mechanism is still unclear. We report a cas...
How Ancient and Modern Acupuncture Heal - Possible Replacement of Acupuncture with New Quantum Technologies
This article is about how acupuncture heals. It all started 40 years ago, at the 8th World Congress on Acupuncture in 1983, where I reported nonlinear mathematical model of one acupuncture meridian. The nonlinear model p...